Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.
Denis B, Lefort A, Flipo RM, Tubach F, Lemann M, Ravaud P, Salmon D, Mariette X, Lortholary O; RATIO Group. Denis B, et al. Among authors: lemann m. Clin Microbiol Infect. 2008 Feb;14(2):183-6. doi: 10.1111/j.1469-0691.2007.01891.x. Epub 2007 Dec 10. Clin Microbiol Infect. 2008. PMID: 18076664 Free article.
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.
Tubach F, Ravaud P, Salmon-Céron D, Petitpain N, Brocq O, Grados F, Guillaume JC, Leport J, Roudaut A, Solau-Gervais E, Lemann M, Mariette X, Lortholary O; Recherce Axée sur la Tolérance des Biothérapies Group. Tubach F, et al. Among authors: lemann m. Clin Infect Dis. 2006 Nov 15;43(10):e95-100. doi: 10.1086/508538. Epub 2006 Oct 16. Clin Infect Dis. 2006. PMID: 17051484 Clinical Trial.
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group. Hamdi H, et al. Among authors: lemann m. Arthritis Res Ther. 2006;8(4):R114. doi: 10.1186/ar1994. Arthritis Res Ther. 2006. PMID: 16859506 Free PMC article.
Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X; RATIO (Research Axed on Tolerance of Biotherapies) Study Group. Sellam J, et al. Among authors: lemann m. Ann Rheum Dis. 2007 Dec;66(12):1610-5. doi: 10.1136/ard.2007.069799. Epub 2007 Apr 24. Ann Rheum Dis. 2007. PMID: 17456528 Free PMC article.
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puéchal X, Wendling D, Lemann M, Ravaud P, Mariette X; RATIO group. Salmon-Ceron D, et al. Among authors: lemann m. Ann Rheum Dis. 2011 Apr;70(4):616-23. doi: 10.1136/ard.2010.137422. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177290
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X; Research Axed on Tolerance of Biotherapies Group. Tubach F, et al. Among authors: lemann m. Arthritis Rheum. 2009 Jul;60(7):1884-94. doi: 10.1002/art.24632. Arthritis Rheum. 2009. PMID: 19565495 Free PMC article.
TNF alpha antagonist therapy and safety monitoring.
Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, Constantin A, Fautrel B, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Huet I, Jullien D, Launay O, Lemann M, Maillefert JF, Marolleau JP, Martinez V, Masson C, Morel J, Mouthon L, Pol S, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Sudre A, Tran TA, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J. Pham T, et al. Among authors: lemann m. Joint Bone Spine. 2011 May;78 Suppl 1:15-185. doi: 10.1016/S1297-319X(11)70001-X. Joint Bone Spine. 2011. PMID: 21703545
[Bone and joints in inflammatory bowel disease].
Lemann M, Bonnet J, Allez M, Gornet JM, Mariette X. Lemann M, et al. Gastroenterol Clin Biol. 2004 May;28(5 Suppl):D75-82. doi: 10.1016/s0399-8320(04)94991-3. Gastroenterol Clin Biol. 2004. PMID: 15213667 Free article. Review. French. No abstract available.
218 results